Allianz Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.59M | Sell |
89,152
-753
| -0.8% | -$28.2K | ﹤0.01% | 1320 |
|
|
2025
Q4 | $3.13M | Sell |
89,905
-63,491
| -41% | -$4.99M | ﹤0.01% | 1365 |
|
|
2025
Q3 | $12.7M | Buy |
153,396
+104
| +0.1% | +$7.53K | 0.01% | 749 |
|
|
2025
Q2 | $11.3M | Sell |
153,292
-8,902
| -5% | -$645K | 0.01% | 773 |
|
|
2025
Q1 | $18.5M | Sell |
162,194
-906
| -0.6% | -$55.1K | 0.02% | 603 |
|
|
2024
Q4 | $8.22M | Buy |
163,100
+6,700
| +4% | +$351K | 0.01% | 817 |
|
|
2024
Q3 | $7.24M | Sell |
156,400
-25,357
| -14% | -$901K | 0.01% | 870 |
|
|
2024
Q2 | $5.91M | Sell |
181,757
-19,136
| -10% | -$524K | 0.01% | 883 |
|
|
2024
Q1 | $5.06M | Buy |
200,893
+152,075
| +312% | +$3.59M | 0.01% | 871 |
|
|
2023
Q4 | $1.59M | Buy |
48,818
+16,422
| +51% | +$451K | ﹤0.01% | 1416 |
|
|
2023
Q3 | $883K | Sell |
32,396
-1,008
| -3% | -$29.2K | ﹤0.01% | 1748 |
|
|
2023
Q2 | $743K | Sell |
33,404
-9,496
| -22% | -$219K | ﹤0.01% | 1634 |
|
|
2023
Q1 | $929K | Buy |
42,900
+31,930
| +291% | +$700K | ﹤0.01% | 1709 |
|
|
2022
Q4 | $223K | Buy |
+10,970
| New | +$275K | ﹤0.01% | 1854 |
|
|
2021
Q3 | – | Sell |
-33,551
| Closed | -$738K | – | 2559 |
|
|
2021
Q2 | $738K | Sell |
33,551
-180,874
| -84% | -$4.03M | ﹤0.01% | 1870 |
|
|
2021
Q1 | $5.1M | Buy |
214,425
+187,091
| +684% | +$4.99M | ﹤0.01% | 1060 |
|
|
2020
Q4 | $715K | Sell |
27,334
-9,606
| -26% | -$202K | ﹤0.01% | 1561 |
|
|
2020
Q3 | $643K | Sell |
36,940
-3,048
| -8% | -$48.6K | ﹤0.01% | 1545 |
|
|
2020
Q2 | $672K | Buy |
+39,988
| New | +$562K | ﹤0.01% | 1961 |
|
|
2018
Q3 | – | Sell |
-98,450
| Closed | -$1.55M | – | 2615 |
|
|
2018
Q2 | $1.55M | Buy |
98,450
+79,565
| +421% | +$1.38M | ﹤0.01% | 2044 |
|
|
2018
Q1 | $311K | Sell |
18,885
-40,245
| -68% | -$746K | ﹤0.01% | 2476 |
|
|
2017
Q4 | $1.07M | Sell |
59,130
-2,515
| -4% | -$45.5K | ﹤0.01% | 2217 |
|
|
2017
Q3 | $1.19M | Buy |
61,645
+42,760
| +226% | +$638K | ﹤0.01% | 2189 |
|
|
2017
Q2 | $224K | Sell |
18,885
-119,495
| -86% | -$1.3M | ﹤0.01% | 2560 |
|
|
2017
Q1 | $1.52M | Sell |
138,380
-733
| -0.5% | -$6.44K | ﹤0.01% | 2092 |
|
|
2016
Q4 | $1.01M | Sell |
139,113
-18,167
| -12% | -$142K | ﹤0.01% | 2210 |
|
|
2016
Q3 | $1.02M | Buy |
+157,280
| New | +$915K | ﹤0.01% | 2201 |
|
|
2016
Q2 | – | Sell |
-23,720
| Closed | -$111K | – | 2557 |
|
|
2016
Q1 | $111K | Hold |
23,720
| – | – | ﹤0.01% | 2461 |
|
|
2015
Q4 | $118K | Hold |
23,720
| – | – | ﹤0.01% | 2421 |
|
|
2015
Q3 | $89K | Sell |
23,720
-9,315
| -28% | -$47.3K | ﹤0.01% | 2297 |
|
|
2015
Q2 | $199K | Buy |
+33,035
| New | +$203K | ﹤0.01% | 2317 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
Allianz Asset Management's CORT Position: Q1 2026 in Review
Allianz Asset Management reduced its Corcept Therapeutics (CORT) stake by 0.84% in Q1 2026, selling an estimated $28.2K and leaving 89,152 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1320.
Allianz Asset Management first reported a position in CORT in Q2 2015 and has held it in 31 quarters since. The position peaked at $18.5M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Allianz Asset Management held 89,152 shares of Corcept Therapeutics worth $3.59M as of Q1 2026.
- Allianz Asset Management sold 753 Corcept Therapeutics shares in Q1 2026, an estimated $28.2K.
- Corcept Therapeutics made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1320 holding.
- Allianz Asset Management first reported a position in Corcept Therapeutics in Q2 2015 and has held it in 31 quarters since.
- Allianz Asset Management's Corcept Therapeutics position peaked at $18.5M in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.